Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We ...
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to ...
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to ...
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care ...
The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...
When influence outpaces expertise However, the rise of health content on social media has also fuelled the parallel problem ...
Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...
The US FDA has approved the first ever cell-based gene therapy to treat Wiskott-Aldrich syndrome (WAS).
Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ultimately helping more patients benefit ...
The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot, designed to promote safe access to digital health devices. The pilot ...
Novartis has announced plans to build a new flagship US manufacturing hub in North Carolina. The announcement comes as part of Novartis’ $23bn investment in US infrastructure over the next five years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback